sycrest 10mg sublingual tablets
lundbeck ltd - asenapine maleate - sublingual tablet - 10mg
sycrest 5mg sublingual tablets
lundbeck ltd - asenapine maleate - sublingual tablet - 5mg
abstral 100 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 100 microgram(s) - phenylpiperidine derivatives; fentanyl
abstral 200 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 200 microgram(s) - phenylpiperidine derivatives; fentanyl
abstral 300 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 300 microgram(s) - phenylpiperidine derivatives; fentanyl
abstral 400 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 400 microgram(s) - phenylpiperidine derivatives; fentanyl
abstral 600 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 600 microgram(s) - phenylpiperidine derivatives; fentanyl
abstral 800 microgram sublingual tablets
kyowa kirin holdings b.v. - fentanyl - sublingual tablet - 800 microgram(s) - phenylpiperidine derivatives; fentanyl
fenta sl 267 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 267 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 267 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 267 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.